INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Outset Medical, Inc. - OM
Outset Medical, Inc. (OM)
Company Research
Source: GlobeNewswire
NEW YORK, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Outset Medical, Inc. (“Outset Medical” or the “Company”) (NASDAQ: OM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Outset Medical and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action] On November 10, 2025, Outset Medical issued a press release announcing the Company’s financial results for the third quarter of 2025. Among other items, Outset Medical reported non-GAAP earnings per share of -$0.69, missing consensus estimates by $0.03, and revenue of $29.43 million, missing consensus estimates by $1.27 million. The Company also revised its revenue outlook for 2025 to a range of $115 million to $120 million, down from a prior range of $122 million to $126 milli
Show less
Read more
Impact Snapshot
Event Time:
OM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OM alerts
High impacting Outset Medical, Inc. news events
Weekly update
A roundup of the hottest topics
OM
News
- Analyst Sentiment on Outset Medical (OM) Remains Strong Following Q4 Results [Yahoo! Finance]Yahoo! Finance
- Outset Medical (NASDAQ:OM) had its price target lowered by analysts at BTIG Research from $17.00 to $15.00. They now have a "buy" rating on the stock.MarketBeat
- Outset Medical, Inc. (OM) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Outset Medical outlines 5%–9% revenue growth for 2026 with next-gen Tablo launch and gross margin expansion [Seeking Alpha]Seeking Alpha
- Outset Medical Q4 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
OM
Earnings
- 2/11/26 - Miss
OM
Sec Filings
- 3/4/26 - Form 3/A
- 2/19/26 - Form 4
- 2/19/26 - Form 4
- OM's page on the SEC website